You are here

PT027

Could AstraZeneca's Asthma Drug Candidate Generate Billions?

Motley Fool

Tue, 12/20/22 - 10:44 am

Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication

Fierce Biotech

Wed, 11/9/22 - 10:43 am

Aiming to uproot the market for asthma attacks, AstraZeneca and Avillion tout two PhIII wins for inhaled combo drug

Endpoints

Thu, 09/9/21 - 10:58 am

clinical trials